UK licenses ketamine-like drug for depression

Esketamine, a medication based on ketamine, has been approved by the EU commission meaning that it is now licenced for use in the UK. The decision must now be reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA) to establish whether any extra safety requirements are needed. The National Institute for Health and Care Excellence (NICE) will also now decide whether esketamine will be made available on prescription by NHS doctors.